Holen Sie sich die Stockscreener-App
86.49
0.39%
-0.34
Handel nachbörslich:
86.49
Schlusskurs vom Vortag:
$86.83
Offen:
$86.5
24-Stunden-Volumen:
1.86M
Relative Volume:
1.70
Marktkapitalisierung:
$10.76B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-507.65M
KGV:
-22.31
EPS:
-3.876
Netto-Cashflow:
$-616.24M
1W Leistung:
-16.55%
1M Leistung:
-25.12%
6M Leistung:
+15.98%
1J Leistung:
+68.07%
1-Tages-Spanne:
$84.52
$87.32
1-Wochen-Bereich:
$84.52
$103.30
52-Wochen-Spanne:
$48.24
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Vergleichen Sie PCVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| PCVX | 86.49 | 10.76B | 0 | -507.65M | -616.24M | -3.876 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Curi RMB Capital LLC Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Los Angeles Capital Management LLC Takes $1.02 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte (NASDAQ:PCVX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq
FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com
Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada
FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian
WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat
TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat
Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India
Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia
FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance
Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks
Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK
Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK
Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com
Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks
Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan
Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia
Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com
Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com
Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK
Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey
Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN
Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat
China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Creative Planning Buys 10,245 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte stock holds $160 target with Buy rating from BTIG By Investing.com - Investing.com Canada
Moody Aldrich Partners LLC Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
How To Trade (PCVX) - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Brokerages - MarketBeat
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):